DYSPORT A (Ipsen Pty Ltd)
Product name
DYSPORT A
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
199 working days (255)
Active ingredients
clostridium botulinum type a toxin haemagglutinin complex
Registration type
EOI
Indication
DYSPORT (powder for injection) is now also indicated for symptomatic treatment of focal spasticity of upper limbs in children aged 2 years and older.
This webpage on the TGA website was printed on 12 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/prescription-medicines-registrations/dysport-ipsen-pty-ltd-0